Customization: | Available |
---|---|
CAS No.: | 62568-57-4 |
Formula: | C35h48n10o15 |
Still deciding? Get samples of US$ 5/vial
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Bosi Huike Factory Supply Injection Peptides in Vials Us Warehouse Janoshik Lab Testing Peptides Selank Dsip CAS 129954-34-3 5mg 10mg Vials Mt2 Tirz Semag Semax Ll37 Weight Lose HMG 75iu Retatrutide
Product name | Tirz |
Appearance | White powder |
Purity | 99% |
Storage | Keep in a cool, dry, dark location in a tightly sealed container or cylinder. |
Shelf Life | 24 Months |
Item | Specification | Results |
Appearance | White Powder | White Powder |
Assay | 93.0%-102.0% | 99.80% |
Identification A. Hplc |
Retention Time Conforms To That Of The Reference Standard | Conforms |
B. Amino Acids | Asp: 0.90-1.10;Glu: 0.90-1.10 Pro: 0.90-1.10;Gly: 0.90-1.10 Leu: 0.90-1.10;Tyr: 0.7-1.05 Half-Cys: 1.4-2.1;Ile: 0.90-1.10 |
Conforms |
Ph | 3.0-6.0 | 5.0 |
Related Substances (Hplc) |
Impurity A≤1.5% | 0.15% |
Impurity B≤1.5% | 0.20% | |
Impurity C≤1.5% | Not Detected | |
Other Single Impurity≤0.5% | 0.13% | |
Total Impurities≤5.0% | 0.7% | |
Acetic Acid (Hplc) | 6.0%-10.0% | 7.1% |
Water(Kf) | Nmt 5.0% | 1.4% |
Bacterial Endotoxins | Less Than 300 Iu/Mg | Conforms |
Acn(Gc) | Not More Than 0.041% | Conforms |
Meoh(Gc) | Not More Than 0.3% | Conforms |
Triethyla mine(Gc) | Not More Than 0.032% | Conforms |
Retatrutide is a glucose-dependent insulinotropic polypeptide (GIP)/glucagon-like peptide 1 (GLP)/glucagon (GCG) triple receptor agonist. The safety and effectiveness of GLP targeted therapy after its release on the market has led to research on incretin therapy targeting multiple mechanisms. Because the regulation of energy metabolism itself involves multiple hormones, drugs targeting multiple signaling pathways may have synergistic effects, thus Make the therapeutic effect more significant.
This is a Phase 2, double-blind, randomized, placebo-controlled trial. The study included 338 adult obese subjects without type 2 diabetes, all of whom were obese [body mass index (BMI) >30 kg/m2] or overweight (BMI 27-30 kg/m2) and had at least one weight-related disease. . Randomly assigned in a 2:1:1:1:1:2:2 ratio to receive retatrutide 1 mg, 4 mg (initial dose 2 mg), 4 mg (initial dose 4 mg), 8 mg (initial dose 2 mg) , 8 mg (initial dose 4 mg), 12 mg (initial dose 2 mg), or placebo for 48 weeks. The results showed that at the 24th week of treatment, patients using retatrutide 1 mg, 4 mg, 8 mg, 12 mg and placebo had an average weight loss of 7.2%, 12.9%, 17.3%, 17.5% and 1.6% respectively; at the 48th week of treatment time, the average reductions were 8.7%, 17.1%, 22.8%, 24.2% and 2.1% respectively.
Storage:
Store in tight, light-resistant containers, avoid exposure to direct sunlight, moisture and excessive heat.
Shelf Life: 24 months.
Freeze dried powder can be transported for short distances at room temperature. Once you receive the goods, please immediately store them in the refrigeration room. After mixing with sterile water, it should be used within one week.
Packing & Delivery
Payment & Workshop